We are highly motivated to improve care, medicines, devices, diagnostics, therapies and patient journeys. For this we build fast growing companies in East and West, create hundreds, even thousands, of healthcare jobs and excellent returns for investors. Our companies deliver high-quality care and products, supported by world renowned healthcare institutions such as Harvard Medical School teaching hospitals. Innovation is a key differentiator and creates competitive advantage. Novel solutions are not always easy to implement, but open new horizons for the provision of higher quality care, better cost control, and ultimately, greater impact.
Our focus on people is fundamental for creating a true strategic partnership between us and the companies we invest in. Our investment strategy is clear and transparent: we focus on expansion and growth capital investments. We work with the best possible partners in the field, such as our partners on the life science venture capital side (TVM Life Science Management in Munich and Montreal), Harvard Medical School teaching hospitals (such as Spaulding Rehabilitation Network), the inventors of IVF (Bourn Hall Clinic), large accreditation institutions (such as JCI), patient centric care organizations (such as Planetree), regional regulatory bodies, national research institutions (such as the Egyptian National Research Centre), and other important stakeholders of the industry.
We are in a long-term affiliation with TVM Life Science Management operating out of Munich and Montreal. These companies were built on the foundation laid by our CEO, Dr. Helmut Schuehsler, after starting TVM Capital’s biotech investing strategy in Germany as early as 1991. Under his leadership, TVM Capital became the leading life science investor in Germany, and one of the leading pan-European investors. He started a strong life science team and stepped up the firm’s life science activities in the Boston office from 1998 onwards. As a result, TVM Capital was for many years among the top investors in life sciences on the U.S. East Coast. TVM Life Science Management is currently investing TVM Capital’s seventh life science venture capital fund, focused on early and late stage deals in Europe and North America, focusing mainly on single-asset drug development programs and late stage biomedical companies.
Bourn Hall International teamed up with Bourn Hall Clinic in the UK to bring their world leading In-Vitro Fertilization (IVF) concept to the Middle East and India. Based in the UK, Bourn Hall Clinic was the world’s first IVF clinic and the deal with TVM Capital Healthcare marked its first international expansion. Bourn Hall International has a reference clinic located in Dubai (UAE), and has recently expanded into the city of Al Ain in the Emirate of Abu Dhabi. The founders of Bourn Hall Clinic, Professor Robert Edwards and Patrick Steptoe, are the inventors of IVF after pioneering the field which led to the birth of Louise Brown in 1978. Professor Edwards received the Nobel Prize for Medicine for his achievements in December 2010, and a Knighthood in 2011. More than five million babies have been born worldwide as a result of IVF.
We have signed an umbrella contract with Spaulding Rehabilitation Network in late 2013, as well as individual agreements on behalf of three portfolio companies in the field of long-term care, rehabilitation and home care – ProVita International Medical Center, Cambridge Medical & Rehabilitation Center and Manzil Healthcare Services. The integrated approach between the companies allows patients to receive treatment in the most appropriate environment, according to their needs, whilst guaranteeing a consistent level of quality throughout their transition between care levels. The affiliation with Spaulding gives TVM Capital Healthcare and its post-acute and chronic care companies access to unrivalled experience, knowledge and best practice in the sphere of long-term care and rehabilitation, helping to drive regional standards in the sector. Staff also receive regular education and training by Spaulding representatives and the facilities undertake auditing and evaluation procedures devised to promote clinical excellence.
TVM Capital Healthcare and JCI, a non-profit healthcare accreditation organization, entered a strategic partnership to help increase awareness and efforts related to quality and patient safety across the continuum of care in the Middle East. Under the agreement, JCI provides expert assistance to our portfolio companies.
TVM Capital Healthcare initiated a partnership with Planetree for its existing and past long-term care and rehabilitation portfolio companies. Planetree is a non-profit organization supporting healthcare providers in their quest to become truly patient- and family-focused in their overall care and services provided. In line with the continual organizational effort to achieve excellence through partnerships, each of the portfolio companies will gain access to a plethora of expertise, resources, training and assessments with regards to policies, practices and procedures that truly focus on enhancing patient and family experience throughout their care. The partnership with Planetree ensures the representation of the patients and their families’ voice through a network of over 50,000 local and international focus groups that includes patients, families, as well as staff. As the first organization in the UAE to partner with and aspire for a Planetree accreditation, the objective is to be a change agent in the UAE’s long-term and post-acute healthcare industry.
A protocol of Scientific Collaboration between portfolio company Amecath, Cairo, and the Egyptian National Research Center (NRC) was signed under the patronage of H.E. Dr. Khaled Abdel Ghaffar, Minister of Higher Education, in late 2018. NRC is the largest multidisciplinary R&D centre in Egypt devoted to basic and applied research, including in the medical field. NRC Possesses an impressive scientific & technological infrastructure and man power resources of 4735 research staff. NRC Consists of 14 divisions and 108 departments covering the major areas of industry, health, environment, agriculture, basic sciences and engineering. NRC Is headed by a president with ministerial status, assisted by two vice presidents, one for research and the other for technical affairs.